FDA approves UP-NIH COVID-19 test kits for commercial use
The Food and Drug Administration (FDA) has approved the University of the Philippines-National Institutes of Health (UP-NIH) developed COVID-19 test kits for commercial use.
As of Friday, April 3, UP-NIH has stockpiled 26,000 test kits with the capacity to produce up to 8,000 daily once at full production.
The locally-made test kits can provide results in two hours and are expected to ensure a sustainable supply of testing materials.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics